Biochemistry (Moscow)

, 76:1009 | Cite as

Influence of proteasome inhibitor bortezomib on the expression of multidrug resistance genes and Akt kinase activity

  • L. A. PanischevaEmail author
  • E. S. Kakpakova
  • E. Y. Rybalkina
  • A. A. Stavrovskaya


The goal of this work was to study the mechanisms of ABC family transport proteins’ regulation by a new-generation antitumor drug — the proteasome inhibitor bortezomib (Velcade). ABC transporters determine the multidrug resistance of tumor cells (MDR). We confirmed our previously discovered observation that bortezomib affects the expression of genes involved in the formation of MDR (ABCB1 gene, also known as MDR1, and ABCC1-MRP1), reducing the amount of their mRNA. This effect was found to depend on Akt kinase activity: the Akt activity inhibitor Ly 294002 increased the amount of MRP1 mRNA in KB 8-5 cells. It was also shown that bortezomib increased the amount of Akt kinase phosphorylated form in cell lines of malignant cells KB 8-5 and K 562/i-S9 that overexpressed ABCB1 transporter (Pgp), and did not affect the amount of activated Akt in the corresponding wild-type cells. When exposed to bortezomib, selection of resistant to it cell variants was much faster for a Pgp-overexpressing cell population (compared to wild-type cells). It is shown that bortezomib affects the amount of MRP1 gene mRNA, relocating the multifunctional protein YB-1, dependent on Akt activity, from cytoplasm to nuclei of MCF-7 breast cancer cells. The data indicate that the transcriptional activity of YB-1 might be one of the mechanisms that determine the effect of bortezomib on the amount of MRP1 gene mRNA.

Key words

ABC protein family multidrug resistance of tumors bortezomib Akt kinase 



chronic myeloleukemia


multidrug resistance






  1. 1.
    Yang, Y., Kitagaki, J., Wang, H., Hou, D., and Perantoni, A. O. (2009) Cancer Sci., 100, 24–28.PubMedCrossRefGoogle Scholar
  2. 2.
    Panischeva, L. A., Kakpakova, E. S., Rybalkina, E. Y., and Stavrovskaya, A. A. (2010) Biochemistry (Moscow) Supplement. Series A: Membrane and Cell Biology, 4, No. 2, 220–225.CrossRefGoogle Scholar
  3. 3.
    Voorhees, P. M., Dees, E. C., O’Neil, B., and Orlowski, R. Z. (2003) Clin. Cancer Res., 9, 6316–6325.PubMedGoogle Scholar
  4. 4.
    Codony-Servat, J., Tapia, M. A., Bosch, M., Oliva, C., Domingo-Domenech, J., Mellado, B., Rolfe, M., Ross, J. S., Gascon, P., Rovira, A., and Albanell, J. (2006) Mol. Cancer Ther., 5, 665–675.PubMedCrossRefGoogle Scholar
  5. 5.
    Datta, S. R., Brunet, A., and Greenberg, M. E. (1999) Genes Dev., 13, 2905–2927.PubMedCrossRefGoogle Scholar
  6. 6.
    Krasilnikov, M. A. (2000) Biochemistry (Moscow), 65, 59–67.Google Scholar
  7. 7.
    McCubrey, J. A., Steelman, L. S., Abrams, S. L., Lee, J. T., Chang, F., Bertrand, F. E., Navolanic, P. M., Terrian, D. M., Franklin, R. A., D’Assoro, A. B., Salisbury, J. L., Mazzarino, M. C., Stivala, F., and Libra, M. (2006) Adv. Enzyme Regul., 46, 249–279.PubMedCrossRefGoogle Scholar
  8. 8.
    Scherbakova, E. A., Stromskaya, T. P., Rybalkina, E. Y., Kalita, O. V., and Stavrovskaya, A. A. (2008) Mol. Biol. (Moscow), 42, 430–436.CrossRefGoogle Scholar
  9. 9.
    Scherbakova, E. A., Rybalkina, E. Y., Stromskaya, T. P., and Stavrovskaya, A. A. (2009) Biol. Membr. (Moscow), 26, 184–189.Google Scholar
  10. 10.
    Glavinas, H., Krajcs, P., Cserepes, J., and Sarkad, B. (2004) Curr. Drug Deliv., 1, 27–42.PubMedCrossRefGoogle Scholar
  11. 11.
    Stavrovskaya, A. A. (2000) Biochemistry (Moscow), 65, 95–106.Google Scholar
  12. 12.
    Dean, M., Rzhetsky, A., and Allikmets, R. (2001) Genome Res., 11, 1156–1166.PubMedCrossRefGoogle Scholar
  13. 13.
    Skabkin, M. A., Skabkina, O. V., and Ovchinnikov, L. P. (2004) Adv. Biol. Chem., 44, 3–52.Google Scholar
  14. 14.
    Kohno, K., Izumi, H., Uchiumi, T., Ashizuka, M., and Kuwano, M. (2003) Bioessays, 25, 691–698.PubMedCrossRefGoogle Scholar
  15. 15.
    Matsumoto, K., and Bay, B. H. (2005) J. Mol. Genet. Med., 1, 11–17.PubMedGoogle Scholar
  16. 16.
    Sutherland, B. W., Kucab, J. E., Wu, J., Lee, C., Cheang, M. C. U., Yorida, E., Turbin, D., Dedhar, S., Nelson, C. C., Pollack, M., Grimes, H. L., Miller, K., Badve, S., Huntsman, D., Gilks, B., Chen, M., Pallen, C. J., and Dunn, S. E. (2005) Oncogene, 24, 4281–4292.PubMedCrossRefGoogle Scholar
  17. 17.
    Evdokimova, V., Ruzanov, P., Anglesio, M. S., Sorokin, A. V., Ovchinnikov, L. P., Buckley, J., Triche, T. J., Sonenberg, N., and Sorensen, P. H. B. (2006) Mol. Cell. Biol., 26, 277–292.PubMedCrossRefGoogle Scholar
  18. 18.
    Lozzio, B. B., and Lozzio, C. B. (1979) Leuk. Res., 3, 363–370.PubMedCrossRefGoogle Scholar
  19. 19.
    Mechetner, E. B., and Roninson, I. B. (1992) Proc. Natl. Acad. Sci. USA, 89, 5824–5828.PubMedCrossRefGoogle Scholar
  20. 20.
    Akiyama, S., Fojo, A., Hanover, J. A., Pastan, I., and Gottesman, M. M. (1985) Somat. Cell Mol. Genet., 11, 117–126.PubMedCrossRefGoogle Scholar
  21. 21.
    Soule, H. D., Vazguez, J., Long, A., Albert, S., and Brennan, M. (1973) J. Natl. Cancer Inst., 51, 1409–1416.PubMedGoogle Scholar
  22. 22.
    Vaiman, A. V., Stromskaya, T. P., Rybalkina, E. Y., Sorokin, A. V., Guryanov, S. G., Zabotina, T. N., Mechetner, E. B., Ovchinnikov, L. P., and Stavrovskaya, A. A. (2006) Biochemistry (Moscow), 71, 146–154.CrossRefGoogle Scholar
  23. 23.
    Chertkov, I. L., and Drize, N. I. (2007) Clin. Oncohematol., 1, 12–33.Google Scholar
  24. 24.
    Powers, G. L., Ellison-Zelski, S. J., Casa, A. J., Lee, A. V., and Alarid, E. T. (2010) Oncogene, 29, 1509–1518.PubMedCrossRefGoogle Scholar
  25. 25.
    Stromskaya, T. P., Rybalkina, E. Y., Kruglov, S. S., Zabotina, T. N., Mechetner, E. B., Turkina, A. G., and Stavrovskaya, A. A. (2008) Biochemistry (Moscow), 73, 29–37.CrossRefGoogle Scholar
  26. 26.
    Matsui, W., Wang, Q., and Barber, J. P. (2008) Cancer Res., 68, 190–197.PubMedCrossRefGoogle Scholar
  27. 27.
    Dhillon, J., Astanehe, A., Lee, C., Fotovati, A., Hu, K., and Dunn, K. (2010) Oncogene, 29, 6294–6300.PubMedCrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2011

Authors and Affiliations

  • L. A. Panischeva
    • 1
    Email author
  • E. S. Kakpakova
    • 1
  • E. Y. Rybalkina
    • 1
  • A. A. Stavrovskaya
    • 1
  1. 1.Institute of Carcinogenesis, Blokhin Russian Cancer Research CenterRussian Academy of Medical SciencesMoscowRussia

Personalised recommendations